Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
In the first four months of 2025 alone, Portuguese consumers spent nearly 20 million on GLP-1-based injectables like tirzepatide (Mounjaro) and semaglutide (Wegovy)both of which are officially approved for obesity treatment
&srotate=0)
DISCLOSURES: The authors report no conflicts of interest relevant to the content of this article
Timely delivery matters, especially for temperature-sensitive medication
The published data shows meaningful but modest fat loss in clinical conditions, approximately 1 to 2 kg of additional fat loss over 12 weeks compared to placebo at 1 mg/day
US$ 26.90
US$ 26.28
US$ 24.66
US$ 24.88
